The Impact of Contrast Media on Image Quality in MRI: Simple Review Article
Main Article Content
Abstract
Contrast media (CM) are employed in imaging modalities to amplify the distinctions between bodily tissues in pictures. An optimal contrast agent should attain a remarkably high level of concentration in the tissues while avoiding any detrimental consequences. Regrettably, doing this has thus far proven unattainable, and all current CM options have negative consequences. The growing utilization of CM is expected to result in various challenges, such as ensuring compliance and appropriateness of CM usage, selecting the most suitable contrast agent, addressing off-label use, assessing specific patient populations, and possessing the necessary skills to handle emergency situations that may arise after CM administration. An even more significant and potentially crucial matter is the issue of informed consent. This entails the responsibility to provide patients awaiting the administration of CM with detailed information about the procedure itself, any alternative procedures available, the extent of the risks associated with using CM, and the risks associated with refusing the procedure. This review mainly discusses image quality in MRI, MRI contrast agents complexes, and effect on image.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Themes U. Intravascular Contrast Media for Radiography, CT, MRI and Ultrasound. Radiology Key. Published March 2, 2016. https://radiologykey.com/intravascular-contrast-media-for-radiography-ct-mriand-ultrasound/
Lusic H, Grinstaff MW. X-ray-computed tomography contrast agents. Chem Rev. 2013;113(3):1641-1666. doi:10.1021/cr200358s
Rogers DC, Tadi P. Intravenous contrast. 2020
Seeram E. Computed Tomography: A Technical Review. Radiol Technol. 2018 Jan;89(3):279CT-302CT.
Mazonakis M, Damilakis J. Computed tomography: What and how does it measure? Eur J Radiol. 2016 Aug;85(8):1499-504
Heshmatzadeh Behzadi A, Farooq Z, Newhouse JH, Prince MR. MRI and CT contrast media extravasation: A systematic review. Medicine (Baltimore). 2018;97(9):e0055. doi:10.1097/MD.0000000000010055
Xiao Y, Paudel R, Liu J, Ma C, Zhang Z, Zhou S. MRI contrast agents: Classification and application (Review). International Journal of Molecular Medicine, 2016;38, 1319-1326.
https://doi.org/10.3892/ijmm.2016.2744
Tang JB, Sheng YQ, Hu HJ and Shen YQ. Macromolecular MRI contrast agents: structures, properties and applications. Prog Polym Sci. 2013;38:462– 502.
Geraldes CFGC and Laurent S. Classification and basic properties of contrast agents for magnetic resonance imaging. Contrast Media Mol Imaging. 2009;4:1–23.
Gandhi SN, Brown MA, Wong JG, Aguirre DA and Sirlin CB. MR contrast agents for liver imaging: what, when, how. Radiographics. 2006;26:1621– 1636.
Shokrollahi H. Contrast agents for MRI. Mater Sci Eng C. 2013;33:4485–4497.
Yurt A and Kazanci N. Investigation of magnetic properties of various complexes prepared as contrast agents for MRI. J Mol Struct. 2008;892:392– 397.
Zhen Z, Xie J. Development of manganese-based nanoparticles as contrast probes for magnetic resonance imaging. Theranostics. 2012;2(1):45-54. doi:10.7150/thno.3448
Paratala BS, Jacobson BD, Kanakia S, Francis LD, Sitharaman B. Physicochemical characterization, and relaxometry studies of micro-graphite oxide, graphene nanoplatelets, and nanoribbons. PLoS One. 2012;7 (6):e38185. doi:10.1371/journal.pone.0038185
Na HB, Song IC and Hyeon T. Inorganic nanoparticles for MRI contrast agents. Adv Mater. 2009;21:2133–2148.
Taylor RM, Huber DL, Monson TC, Ali AM, Bisoffi M, Sillerud LO. Multifunctional iron platinum stealth immunomicelles: targeted detection of human prostate cancer cells using both fluorescence and magnetic resonance imaging. J Nanopart Res. 2011;13(10):4717-4729. doi:10.1007/s11051-011-0439-3
Bumb A, Brechbiel MW, Choyke P. Macromolecular and dendrimer-based magnetic resonance contrast agents. Acta Radiol. 2010;51(7):751-767. doi:10.3109/02841851.2010.491091
Verloh N, Utpatel K, Haimerl M, et al. Liver fibrosis and Gd-EOB-DTPAenhanced MRI: A histopathologic correlation. Sci Rep. 2015;5:15408. Published 2015 Oct 19. doi:10.1038/srep15408
Sireci S. Clinical utility of barium sulfate products: Formulation determines appropriate use. Applied Radiology, 2021;50(4), 1-7.
Mesbahi A, Famouri F, Ahar MJ, Ghaffari MO, Ghavami SM. A study on the imaging characteristics of Gold nanoparticles as a contrast agent in X-ray computed tomography. Polish Journal of Medical Physics and Engineering, 2017;23(1), 9.